Table 4 Annual all-cause and MDD-related costs during the follow-up period
Annual all-cause costs (US$) | Annual MDD-related costs (US$) | |||||
|---|---|---|---|---|---|---|
Patients with relapse (n = 7093) | Patients without relapse (n = 7093) | p value | Patients with relapse (n = 7093) | Patients without relapse (n = 7093) | p value | |
Hospitalization costs | 785 (4959) | 573 (4713) | .0089 | 32 (469) | 3 (46) | <.0001 |
ED costs | 1028 (3451) | 429 (1344) | <.0001 | 24 (222) | 7 (158) | <.0001 |
Laboratory costs | 558 (2023) | 422 (1484) | <.0001 | 9 (85) | 8 (91) | .3310 |
Outpatient costs | 6391 (16,625) | 5537 (14,548) | .0011 | 703 (1773) | 591 (1498) | <.0001 |
Other costs | 1242 (4930) | 1122 (5349) | .1671 | 19 (213) | 11 (217) | .0284 |
Medical costs | 10,004 (21,126) | 8084 (19,460) | <.0001 | 787 (1976) | 619 (1553) | <.0001 |
Pharmacy costs | 2590 (7593) | 2361 (9827) | .1210 | 251 (893) | 244 (722) | .5997 |
Total costs (pharmacy and medical) | 12,594 (24,003) | 10,445 (23,288) | <.0001 | 1038 (2201) | 863 (1763) | <.0001 |